Recent Posts
Practice Area
In line with the Food Safety and Standards Act, 2006, the Food Safety and Standards Authority of India (FSSAI) firmly prohibits the commercialization of human milk and its derivatives. This directive extends to state licensing authorities, urging them to abstain from granting licenses for such activities.
Human milk, renowned for its array of bioactive molecules safeguarding against infections, inflammation, and fostering immune development, has been a cornerstone of newborn nutrition for centuries. Donating breast milk for infants in need has been a longstanding tradition globally, spanning over a century.
Outlined in the national guidelines on Lactation Management Centres (LMCs) in Public Health Facilities, the voluntary nature of breast milk donation is emphasized. It’s essential to note that such donations should occur solely within healthcare facilities and not be promoted in community settings.
The ramifications of commercializing human milk are manifold. Firstly, it perpetuates the exploitation of low-income women, jeopardizing both their well-being and that of their children, while catering primarily to affluent consumers. Moreover, concerns regarding quality and safety loom large, with potential risks stemming from pathogen transmission and chemical residues.
Furthermore, the commodification of human milk exacerbates socioeconomic disparities, as the exorbitant costs associated with it may impede access for marginalized populations.
In conclusion, the FSSAI’s stance against the commercialization of human milk underscores the imperative to prioritize public health and equity. Understanding the multifaceted risks and implications is crucial in safeguarding the well-being of both mothers and infants.
This is to further inform that FSSAI License in India is required by the business engaged in food business